COVID-19: Novavax gets European approval

Science unscripted - A podcast by DW.COM | Deutsche Welle

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

Several months behind schedule, the Novavax protein subunit vaccine has been approved for use in Europe. This is potentially very important news for the fight against COVID-19. Why?

Visit the podcast's native language site